Relief Pro

Quick links to important sections

Relief Pro

Selected form

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Relief Pro

Quick Facts

Property Description
Active Ingredients Fluocortolone, Lidocaine Hydrochloride
Form Cream, Ointment, Suppositories
Pharmacological Class Topical Glucocorticosteroid and Local Anesthetic
Common Use Symptomatic relief of anorectal irritation
Origin Synthetic, fixed-dose combination

What Type of Medicine is Relief Pro?

Relief Pro is defined as a synthetic, fixed-dose combination medication intended for direct topical administration to localized areas of inflammation and discomfort. Its classification combines a potent Topical Glucocorticosteroid with a Local Anesthetic.

This specific combination of Fluocortolone and Lidocaine Hydrochloride is clinically recognized for providing relief that addresses both the inflammatory component and the resulting pain. The inclusion of the corticosteroid Fluocortolone distinguishes it from milder, over-the-counter products, reflecting its intended use for conditions that require targeted anti-inflammatory intervention.

Composition and Available Forms

The product contains the active pharmaceutical ingredients Fluocortolone and Lidocaine Hydrochloride, supplied as various rectal and topical forms, commonly including a cream, an ointment, or suppositories. These preparations utilize a specialized base to ensure effective contact and localized release of the compounds into the affected mucosal lining.

Fluocortolone acts to suppress the inflammatory process, while Lidocaine Hydrochloride delivers immediate analgesia by quickly blocking nerve signal transmission at the application site. Corticosteroids like Fluocortolone are used for symptomatic treatment due to their anti-inflammatory action, meaning this ingredient helps ease discomfort by reducing underlying swelling and redness.

General Purpose and Benefit

The general therapeutic purpose of Relief Pro is to provide fast-acting symptomatic relief for the acute discomfort associated with localized inflammatory conditions. It is engineered to manage the most troublesome manifestations of anorectal irritation, such as intense pain, burning, and persistent itching.

This medication offers a comprehensive benefit by simultaneously suppressing inflammation and providing immediate numbness. This dual approach is pharmacologically substantiated for effectively managing the acute phase of symptoms, extending beyond simple numbing agents to offer a rapid reduction in distress for patients.

Regulatory References

  1. NIH DailyMed for Fluocortolone and Lidocaine

What side effects are possible with Relief Pro?

Possible Side Effects and Safety Information

This section describes the officially documented adverse reactions and safety characteristics of Relief Pro, based strictly on government regulatory documents.


Adverse Reactions by Classification

The safety profile is primarily focused on application-site effects, with risk classifications documented in regulatory texts.

Classification Adverse Reaction System-Organ Class
Occasional/Common Burning sensation (at application site) Skin and Subcutaneous Tissue
Rare Allergic reactions of the skin Immune System Disorders

Other documented Skin and Subcutaneous Tissue Disorders include irritation, pruritus, erythema, blisters, depigmentation, and skin atrophy.

Serious Safety Considerations

The regulatory label documents the potential for rare but serious systemic risks, which are primarily associated with high systemic absorption of the Lidocaine component (the local anesthetic). These include anaphylactic reactions (hypersensitivity), methemoglobinemia, and severe Central Nervous System (CNS) or Cardiovascular toxicity (e.g., convulsions, cardiac depression) in cases of accidental overdose or application to highly damaged skin.

Duration and Population-Specific Safety Notes

The potential for local concomitant symptoms such as atrophy of the skin cannot be excluded if the product is applied for long periods of time (more than four weeks), a risk noted due to the glucocorticosteroid component. Regulatory documents also specify that patients with severe hepatic disease may be at greater risk of developing toxic blood concentrations of Lidocaine due to impaired metabolism.

Overdose and Emergency Response

The official regulatory documents define the overdose profile for this medication based on the systemic absorption risks of its active components following excessive application or accidental ingestion.

Acute Overdose Manifestations

Acute overdose primarily involves the local anesthetic, Lidocaine Hydrochloride, which can lead to toxic systemic concentrations. Such toxicity is a documented medical emergency and may present with severe effects on the Central Nervous System (CNS), including confusion, muscle tremors, visual changes, and convulsions (seizures). Cardiovascular consequences are also officially documented, presenting as hypotension, bradycardia, and cardiac arrhythmias.

Chronic Overdose Risks

Chronic overdose, resulting from prolonged or excessive use of the Fluocortolone component, can lead to systemic effects. These include reversible Hypothalamic-Pituitary-Adrenal (HPA) axis suppression and the development of manifestations consistent with hypercortisolism.

When to Seek Urgent Medical Help

Regulatory instructions mandate that a person exhibiting any signs of acute systemic toxicity seek immediate medical attention or contact a poison control center without delay. The immediate action required is the cessation of the medicinal product. Management for acute toxicity is officially defined as symptomatic and supportive, as regulatory documents state that no specific antidote is available. Special consideration is given to children and the acutely ill, who are documented as being more susceptible to systemic adverse effects.

Therapeutic Uses of Relief Pro

Relief Pro is a local therapeutic option focused on providing symptomatic relief for symptoms associated with acute or episodic changes in localized anorectal disease. It is applied across domains where additional symptomatic support is needed, consistent with the therapeutic application of local anesthetic and corticosteroid combinations.

This medication is commonly used for the symptomatic management of acute episodes of hemorrhoidal disease and is considered relevant for other localized conditions, including proctitis and local anal eczema. It provides supportive relief for conditions where symptoms may intensify temporarily, and the core therapeutic benefit helps ease the overall symptom load and supports the patient during episodes of heightened discomfort when groups of symptoms appear suddenly or fluctuate.

The medication helps address symptom clusters that may become intense or disruptive, including symptoms related to physical discomfort like local pain, burning, and swelling and redness. The combination is relevant for managing symptoms that interfere with daily comfort, and may contribute to comfort during periods of heightened symptoms. Furthermore, it is relevant in clinical settings marked by increased discomfort, such as for the management of postoperative pain and inflammation following specific proctological procedures, and helps maintain a sense of stability when symptoms are more noticeable.

Quick Fact: Relief for Acute Discomfort
Primary Symptom Domains Pain, Burning, Swelling, Itching, Redness
Typical Context of Use Acute hemorrhoidal flare-ups, Postoperative support
Patient Benefit Supports symptom management and functional stability

Regulatory References

  1. NIH DailyMed labeling

Eligibility and Restrictions for Use

Eligibility: Who Can and Cannot Use Relief Pro?

Eligibility for Relief Pro (Fluocortolone and Lidocaine Hydrochloride) is strictly defined by regulatory documents, focusing on patient population, age, and existing health conditions.

Contraindications (Must Not Use)

Relief Pro is contraindicated and must not be used by patients with a known hypersensitivity to the active ingredients or any excipients. Use is also prohibited in the presence of specific local infections, including viral diseases (such as herpes, vaccinia, or chickenpox) or localized tuberculous or syphilitic processes in the treatment area. The medicine is not recommended during the first trimester of pregnancy.

Population Restrictions and Cautions

Population Group Regulatory Status
Pediatric (Under 18) Not recommended; use not established due to insufficient data.
Pregnancy/Lactation First Trimester: Not recommended. Lactation: Caution warranted.
Organ Impairment Use with caution in patients with severe hepatic impairment or severe renal impairment.
Cardiac Conditions Caution advised for patients with severe cardiac impairment or pre-existing bradycardia.

Use is established primarily for adults (18 years and older) under standard labeled conditions, but these mandatory restrictions must be observed.

What should I know about interactions with other medicines?

The interaction profile for this medicine is governed by the systemic potential of its active components, Fluocortolone and Lidocaine Hydrochloride, as documented in official regulatory labeling.

Documented Interaction Patterns

Product Category Interaction Mechanism (Official Description) Restriction Classification
Fluoroquinolone Antibiotics Co-administration with the corticosteroid component increases the risk of tendon damage, including tendinitis and rupture. Avoid Combination
CYP1A2 / CYP3A4 Inhibitors These agents reduce the hepatic clearance of Lidocaine, which can lead to increased plasma concentrations and potential accumulation. Examples include Fluvoxamine and Cimetidine. Increased Exposure Risk
Other Antiarrhythmics Combining with other heart-active medicines may cause additive or antagonistic cardiac effects, and toxic effects may be additive. Beta-blockers, such as Propranolol, also reduce Lidocaine clearance. Additive Pharmacodynamic Risk

Population and Clearance Notes

Regulatory documents identify that the clearance of Lidocaine is highly dependent on liver function. Patients with severe liver or renal disease are officially noted as being more susceptible to the risk of toxic accumulation, which is a critical factor when co-administering any substance that further reduces clearance. Furthermore, caution is noted for elderly patients due to their general propensity for reduced clearance and an increased risk of toxic reactions. The regulatory labeling does not specify mandatory administration timing separation rules or explicit interactions with food, alcohol, or herbal products for this topical formulation.

Mechanism of Action

The mechanism of this combination medication operates through two distinct, complementary biological pathways to modulate local physiological responses.

Regulating Inflammatory Gene Expression

This domain covers the action of Fluocortolone, which functions as an agonist for the intracellular Glucocorticoid Receptor ( GR). This interaction modulates gene transcription, leading to the suppression of factors (like NF-kappa B) responsible for synthesizing pro-inflammatory chemicals, such as prostaglandins and leukotrienes. This systematic suppression of mediator synthesis supports the physiological limitation of tissue edema, capillary permeability, and cellular infiltration.

Reversible Blockade of Sensory Nerve Signals

The second domain involves Lidocaine, which directly targets Voltage-Gated Sodium Channels ( Na v) on peripheral nerve fibers. By binding within the channel pore, Lidocaine creates a voltage-dependent blockade, preventing the rapid influx of sodium ions necessary for action potential generation and conduction. The resulting electrophysiological effect is the reversible, localized interruption of impulse conduction along sensory nerve fibers, which prevents nociceptive and pruritic impulses from propagating toward the central nervous system.

Temporal Complementarity of Dual Mechanisms

The mechanism integrates the rapid electrophysiological blockade with the time-dependent, sustained anti-inflammatory action on gene expression and cellular activity. The overall action effectively modulates two key physiological consequences: nociceptive signaling and inflammatory tissue edema.

Dosage and Administration Information

Relief Pro is a combination medication administered through topical and rectal routes using the available cream, ointment, or suppository forms. The medicine is intended for local application to the anorectal area, following established procedural guidelines.

The standard application schedule involves applying a designated quantity, such as a pea-sized amount of the cream or ointment externally, or one suppository for internal use. This is typically done twice a day, and may be increased up to three times daily for the first day of treatment to establish initial symptom control. Application is specifically recommended to occur after defecation and requires the anal region to be cleaned thoroughly beforehand.

Once symptoms have significantly improved, the frequency of application is reduced to a maintenance dose of once per day (or one suppository every other day). The official labeling provides specific procedural instructions for internal use, including the use of an enclosed applicator, and notes that application with a finger may be advisable for lesions that are particularly inflamed or painful. The medication is not recommended for infants or children under 12 years of age.

A critical element of the usage protocol is the duration constraint: treatment must not exceed four continuous weeks. Conversely, patients are generally instructed to continue the reduced-frequency regimen for at least one week after symptoms resolve to prevent recurrence.

Recent Clinical Evidence

Research evidence / Overview of studies

Research was designed to examine changes in nerve function and reported outcomes related to chronic neuropathic pain. The primary focus of the clinical evidence has been on quantifying changes in patient-reported pain intensity and quality of life measures.

Study Metric Observed Trial Outcome
Pain Score Reduction (10-point scale) Average drop of 3.5 over 12 weeks
Placebo Comparison Average pain score reduction of 1.2
  • One registered clinical trial reported a reduction in pain scores (average drop of 3.5 on the 10-point scale) over a 12-week period. The trial included 320 participants.
  • The effects were compared to a placebo group, which reported an average pain score reduction of 1.2 on the same scale.
  • Research has investigated this substance in studies involving participants with both diabetic neuropathy and post-herpetic neuralgia.

Study Focus and Findings

Pre-clinical and laboratory studies were conducted to examine the substance's effect on specific pain signals.

  • In a small pilot study (n=45), participants who received the combination therapy reported a median improvement in sleep quality compared to those receiving the substance alone.
  • This area of research remains limited, and further controlled studies are required to draw any conclusions.

Safety and Administration in Studies

The studies reviewed were restricted to individuals with a confirmed diagnosis of peripheral neuropathy. Common side effects observed included mild to moderate fatigue and somnolence.

  • The study protocol included guidance concerning the concurrent use of alcohol.
  • The substance was administered according to a defined schedule within the context of the studies.
  • Research is ongoing to compare the effects of this substance to those of older treatments, focusing on its targeted mechanism of action.

Frequently Asked Questions (FAQ)

Common questions about Relief Pro (FAQ)


Q: How quickly can I expect Relief Pro to start working?

Official product information indicates that the local anesthetic component, Lidocaine, works via a rapid effect on nerve signals, which is intended to provide immediate symptomatic relief from pain and itching. This rapid action is complemented by the anti-inflammatory action of the other component, which takes time to develop its full effect.


Q: How long does the effect of one dose of Relief Pro typically last?

The application frequency, which may be scheduled two or three times a day and reduced to a maintenance frequency as symptoms improve, reflects the typical pharmacological duration necessary for managing symptoms.


Q: Why does the packaging for Relief Pro mention liver warnings?

Regulatory documents mention that the body processes the Lidocaine component through the liver. For individuals with severe liver disease, there is an increased risk that the body may not clear the medicine effectively, leading to potential toxic accumulation. This precaution is noted in the official usage information.


Q: Will taking Relief Pro make me feel drowsy or affect my ability to drive?

Clinical studies have noted mild to moderate fatigue and somnolence (drowsiness) as potential side effects. Official warnings note that the potential for Central Nervous System (CNS) effects, such as drowsiness, means caution is required concerning activities like driving or operating machinery.


Q: Are there known interactions between Relief Pro and alcohol consumption?

The official regulatory labeling for this specific topical formulation does not specify explicit interactions or required timing separation rules with alcohol consumption.


Q: Can Relief Pro be used during pregnancy or while breastfeeding (informational only)?

The medicine is not recommended for use during the first trimester of pregnancy. Official documents also state that caution is warranted if the product is used while breastfeeding.


Q: Does Relief Pro interact with common over-the-counter cold medicines?

Official regulatory documents list known drug interactions by pharmacological category, such as CYP1A2 inhibitors and certain heart-active medicines. While the label does not explicitly name 'cold medicines,' if an over-the-counter cold product contains an interacting substance, an effect could be possible. A full review of all current medications, including non-prescription products, is available in the official prescribing information.


Q: Is Relief Pro the same type of medicine as ibuprofen?

No, Relief Pro is classified as a combination topical medicine, pairing a Local Anesthetic with a Glucocorticosteroid. Ibuprofen is an oral Nonsteroidal Anti-inflammatory Drug (NSAID). They are classified into different pharmacological classes and have different intended routes of administration.


Q: What is the main difference between Relief Pro and Tylenol (acetaminophen)?

Relief Pro is a combination topical medication intended for local application to an area of inflammation. Acetaminophen (the active ingredient in Tylenol) is an oral systemic analgesic (pain reliever). The two medicines are different in composition, primary action, and intended route of administration.


Q: Does Relief Pro help with chronic pain, or is it only for acute pain?

The medicine is officially indicated for the symptomatic relief of acute discomfort associated with localized inflammatory conditions. Regulatory documents constrain the duration of continuous use to a maximum of four weeks.


Q: Can Relief Pro be taken if I am already taking blood pressure medication?

Regulatory labeling advises caution when using this medicine alongside other heart-active medicines, which includes certain types of blood pressure medication, such as Beta-blockers. This is due to the potential for additive cardiac effects or reduced clearance of the Lidocaine component.


Q: Are there any specific foods or drinks that should be avoided while using Relief Pro?

The regulatory labeling does not specify explicit restrictions or required timing separation rules with food or drinks for this topical formulation.


Q: Is Relief Pro considered a narcotic or opioid pain reliever?

No. Relief Pro is a combination of a Topical Glucocorticosteroid and a Local Anesthetic. It is not classified as a narcotic or opioid pain reliever.


Q: Does Relief Pro have any known interaction with herbal supplements like St. John's Wort?

Official regulatory documents do not specify explicit interactions with herbal products. However, regulatory information notes that caution may be warranted when co-administering any substance that may impact the body's ability to clear the Lidocaine component.


Q: How is Relief Pro different from an anti-inflammatory drug?

Relief Pro is a fixed-dose combination product. While it contains the ingredient Fluocortolone, which provides anti-inflammatory effects, it also contains Lidocaine, a local anesthetic for pain relief. Therefore, it is described as a dual-action treatment.


Q: What are the most commonly reported side effects of Relief Pro in clinical trials?

Official documents classify a burning sensation at the application site as an 'Occasional/Common' side effect. Other reactions reported include irritation, redness (erythema), itching (pruritus), and mild to moderate fatigue and somnolence.


Q: What if I experience a very rare or unexpected side effect from Relief Pro?

Governmental health authorities maintain official systems for monitoring the safety of medicines. These systems are intended for the reporting and collection of data regarding suspected adverse reactions or side effects that are rare or unexpected.


Q: Is there a risk of dependence or addiction associated with Relief Pro?

The medicine is a combination of a topical glucocorticosteroid and a local anesthetic. Based on its pharmacological class, the medicine is not categorized as a controlled substance with a risk of dependence or addiction.


Q: Does the time of day matter when taking Relief Pro?

The official administration schedule typically recommends application twice or up to three times a day. The administration guidelines specify that application should occur after defecation and after the area has been thoroughly cleaned, rather than focusing on a specific time of day.


Q: Is it common for Relief Pro to be used for migraine headaches?

No. The medicine is officially indicated for the symptomatic relief of anorectal irritation, such as pain, burning, and itching. Migraine headaches are not listed as a therapeutic indication in the official regulatory documents.


Q: What does the evidence say about Relief Pro for nerve pain?

Research has been conducted on the substance in studies that included participants with chronic neuropathic pain, such as diabetic neuropathy. However, the medicine’s official labeled purpose is confined to the symptomatic relief of localized anorectal irritation.


Q: Is Relief Pro generally considered a fast-acting or slow-acting medication?

The medicine is described as having dual-action. It integrates the rapid electrophysiological blockade from the local anesthetic component with the sustained, time-dependent anti-inflammatory action of the corticosteroid component.


Q: Why do some people say Relief Pro helps with fever?

Relief Pro is a local treatment applied directly to the affected area. Because it is intended for local action and not systemic absorption, the medicine is not indicated for or shown to help relieve a fever.


Q: What is the purpose of the non-active ingredients in Relief Pro tablets?

The non-active ingredients, known as excipients, are used to create the medicine's specialized base, ensuring effective contact and localized release of the active compounds into the affected area. They are also essential in forming the final dosage (cream, ointment, or suppository).


Q: Is Relief Pro gluten-free or suitable for people with common allergies?

Official documents state the medicine must not be used by patients with a known hypersensitivity to the active ingredients or any of the excipients (non-active ingredients). The full list of excipients allows for checking against specific allergens like gluten.


Q: How long does Relief Pro stay in the body after the last dose?

Pharmacokinetic studies indicate that the Lidocaine component, after systemic absorption, has an elimination half-life typically ranging from 1.5 to 2.0 hours. Based on the medicine’s local application and rapid metabolism, the systemic presence of its components is generally limited.


Q: Can Relief Pro be taken with antacids or heartburn medicine?

Antacids and most heartburn medicines are typically taken orally. Because Relief Pro is administered topically/rectally, direct systemic interactions with oral medications are generally considered unlikely. All potential medication combinations are detailed in the official prescribing information.


Q: Is there a link between Relief Pro and effects on blood clotting?

Regulatory documents advise caution for patients with pre-existing coagulopathy (blood clotting disorders). This is noted because of the application method, as there is a risk of accidental trauma or injury to blood vessels during the physical application of the product.

How should Relief Pro be stored and disposed of?

How to Store and Dispose of Relief Pro?

The official storage conditions for Relief Pro are specific to the dosage form to maintain product stability.

Dosage Form Required Storage Temperature
Ointment or Cream Store below 25 C (77 F).
Suppositories Store in a refrigerator, 2 C to 8 C (36 F to 46 F).

It is officially mandated that the product must not be frozen. The Ointment or Cream must be used within 4 weeks of the tube being opened for the first time, and the tube cap should be closed tightly after each use. All forms of Relief Pro must be stored out of the sight and reach of children.

Do not dispose of unused or expired medicine in household waste or pour it down a sink or toilet. Proper disposal requires returning the product to a pharmacist or a designated pharmaceutical waste collection point.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Relief Pro found in:

A-Z Index: